BRD7 and nasopharyngeal carcinoma: Aberrant promoter methylation of BRD7 gene was detected in 18 of 18 (100%) tumor biopsies (Top of Fig. 7A) and 18 of 18 (100%) (Bottom of Fig. 7A) matched blood samples of NPC patients, respectively.